Innate Immunity & Neurodegeneration

The innate immune response is an important regulator of the downstream immune response, and it is becoming increasingly evident that immune dysfunction has impacts on the pathogenesis of multiple disease states, including neurodegeneration. Additionally, mutations in several genes involved in the innate immune response have been associated with neurodegeneration. Discover the latest research on innate immunity and neurodegeneration here.

December 7, 2021

Microglial TREM2 in amyotrophic lateral sclerosis.

Developmental Neurobiology
Manling XieLong-Jun Wu
December 7, 2021

Untangling senescent and damage-associated microglia in the aging and diseased brain.

The FEBS Journal
Pei Y NgDarren J Baker
December 7, 2021

Inflammation-dependent oxidative stress metabolites as a hallmark of amyotrophic lateral sclerosis.

Free Radical Biology & Medicine
Luyang XiongTatiana V Byzova
December 6, 2021
Open Access

Attractin Participates in Schizophrenia by Affecting Testosterone Levels.

Frontiers in Cell and Developmental Biology
Nan LiQingshun Zhao
December 6, 2021

Vitamin D and its' role in Parkinson's disease patients with SARS-CoV-2 infection. A review article.

Interdisciplinary Neurosurgery : Advanced Techniques and Case Management
Ahmed Y AzzamMohammed A Azab
December 6, 2021
Open Access

Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.

Frontiers in Endocrinology
Ingrid Langer, Dorota Latek
December 6, 2021
Open Access

Anti-Inflammatory and Anti-Oxidative Effects of AM404 in IL-1β-Stimulated SK-N-SH Neuroblastoma Cells.

Frontiers in Pharmacology
Matthias ApweilerBernd L Fiebich
December 6, 2021
Open Access

Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders.

Frontiers in Aging Neuroscience
Banglian HuHonghua Zheng
December 6, 2021
Open Access

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease.

Frontiers in Aging Neuroscience
Chao GuMei Wang
December 6, 2021

[Research progress of cell pyroptosis in the mechanism and treatment of glaucoma].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
J R Cao, Z Z Dong
December 6, 2021

[Progress of researches on mechanisms of acupuncture in treatment of Parkinson's disease].

Zhen ci yan jiu = Acupuncture research
Xiao-Bei SunShao-Peng Liu
December 6, 2021

Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease.

Journal of Alzheimer's Disease : JAD
Masoud NeshanGhasem Ahangari
December 6, 2021

Local and remote interactions between macrophages and microglia in neurological conditions.

Current Opinion in Immunology
Séverine Boillée
December 4, 2021

Targeted therapy strategies for melanoma brain metastasis.

Neuro-oncology Advances
Chantal SaberianMichael A Davies
December 4, 2021
Open Access

Microglia Mediate Early Corticostriatal Synapse Loss and Cognitive Dysfunction in Huntingtons Disease Through Complement-Dependent Mechanisms

BioRxiv : the Preprint Server for Biology
D. K. WiltonBeth stevens
December 3, 2021

Neuroinflammation in Huntington's disease: A starring role for astrocyte and microglia.

Current Neuropharmacology
Julieta SabaCarla Caruso
December 2, 2021

Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.

Pharmacology & Therapeutics
Tomás R GuilarteDiana J Azzam

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved